Scleroderma Drug Development (SDD 2018) is a conference dedicated to the latest insights, evelopments and science to elevate clinically effective scleroderma therapeutics.
Topics
- Disease aetiology to more confidently identify disease modifying scleroderma candidates
- From preclinical to clinical development beyond the bleomycin mouse model
- Therapeutic potential of your own fibrosis and inflammatory candidates within systemic sclerosis
Who should Attend
Researchers from academia and industry.
